The number of older adults with HIV will rise sharply over the next 15 years, testing health systems never built for their complex needs. A new report in The Lancet projects that the global number of people aged 50 and older living with HIV will almost double between 2025 and 2040. The total is expected to climb from 11.5 million…
Tag: AIDS 2026
-
Aspen HIV Prevention Pill Deal Expands African Access
Aspen Pharmacare will become a major African supplier of Merck’s experimental monthly HIV prevention pill, alimatravir. The agreement depends on the medicine successfully completing clinical trials and receiving regulatory approval. Merck granted voluntary licenses to seven generic drug manufacturers, including the South African company, to produce and distribute lower-cost versions of the medicine. The drug also goes by its development…